Angela Pellegrini
Optometrist · Wilmington, DENPI 1841453495
Payments from drug & device makers
Across 22 payments — averaging $23.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$219
- Bausch & Lomb Americas Inc.$84
- Johnson & Johnson Vision Care, Inc.$72
- Rxsight Inc$29
- Viiv Healthcare Company$23
- Tarsus Pharmaceuticals, Inc.$21
- plus $68 from 4 others
What the payments were for
- Food & beverage$518100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 10 | $219 |
| Bausch & Lomb Americas Inc. | 3 | $84 |
| Johnson & Johnson Vision Care, Inc. | 2 | $72 |
| Rxsight Inc | 1 | $29 |
| Viiv Healthcare Company | 1 | $23 |
| Tarsus Pharmaceuticals, Inc. | 1 | $21 |
| AbbVie | 1 | $18 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $18 |
| Oyster Point Pharma, Inc. | 1 | $17 |
| Coopervision Inc. | 1 | $15 |
How this compares
$518 in reported general payments places this provider in the 35th percentile of 146 optometrist providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 36 | $724 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $419 |
| Timolol Maleate | 11 | $317 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $163 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Wilmington
- Jennifer TuranoWilmington$42K
- Laura GoldbergWilmington$17K
- Lea MenearWilmington$4K
- Lorna SimmermanWilmington$4K
- Alissa LongWilmington$4K
- Scott TucciWilmington$3K
- Sarah Nowicki-DuczeminskiWilmington$3K
- Daniel BaruffiWilmington$2K
- Jamie WohlhagenWilmington$2K
- Leanne HeuerWilmington$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.